ArticleBrain and behavior2025

Evaluation of CD3+CD56+ NKT and CD19+ B Cells in Assessing the Relapse of Neuromyelitis Optica Spectrum Disorder Patients Treated With Rituximab.

Jing Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.